Opiant Pharmaceuticals, Inc.
OPNT · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $55,234 | $61,005 | $107,421 | $149,855 |
| - Cash | $35,376 | $40,173 | $48,325 | $37,854 |
| + Debt | $16,514 | $14,461 | $14,551 | $17,080 |
| Enterprise Value | $36,371 | $35,293 | $73,647 | $129,081 |
| Revenue | $173,874 | $2,326 | $2,193 | $13,036 |
| % Growth | 7,375.2% | 6.1% | -83.2% | – |
| Gross Profit | $173,874 | $1,809 | $1,767 | $10,115 |
| % Margin | 100% | 77.8% | 80.6% | 77.6% |
| EBITDA | -$9,458 | -$11,295 | -$11,775 | $1,862 |
| % Margin | -5.4% | -485.6% | -536.9% | 14.3% |
| Net Income | -$9,917 | -$11,737 | -$12,588 | $752 |
| % Margin | -5.7% | -504.6% | -574% | 5.8% |
| EPS Diluted | -1.93 | -2.31 | -2.51 | 0.13 |
| % Growth | 16.5% | 8% | -2,030.8% | – |
| Operating Cash Flow | -$4,740 | -$10,625 | -$2,103 | $2,004 |
| Capital Expenditures | -$411 | $0 | $0 | $0 |
| Free Cash Flow | -$5,151 | -$10,625 | -$2,103 | $2,004 |